Modification of blood group A expression in human pancreatic tumor cell lines by inhibitors of N-glycan processing

Courtney Schaffert, Parviz M. Pour, William G. Chaney

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Pancreatic adenocarcinomas induced in Syrian hamsters by N- nitrosobis(2-oxopropyl)amine (BOP) treatment express blood group A (BGA) antigen, which was previously shown by this lab to be expressed on multiantennary asparagine (Asn)-linked glycans attached to membrane glycoproteins. To determine if a similar expression pattern was found in humans, three human pancreatic ductal adenocarcinoma cell lines (CD18, CD11, and Capan 1) from individuals of blood type A were analyzed and shown to express BGA antigen on membrane glycoproteins similar in molecular mass to those found in hamster tumor cells. The BGA antigen was located on Asn- linked oligosaccharides in all three human cell lines, as indicated by loss of activity after peptide:N-glycosidase F (PNGase F) treatment. Also, as shown previously in hamster pancreatic tumor cells, BGA expression at the surface of the human cell lines was blocked by growth of the cells in media containing deoxymannojirimycin (dMM), an inhibitor of mannosidase 1. These results demonstrate that the BGA antigen is on Asn-linked glycans in human pancreatic adenocarcinoma cells and that these glycoproteins are processed similarly to the BGA glycoproteins in hamster pancreatic adenocarcinoma.

Original languageEnglish (US)
Pages (from-to)21-29
Number of pages9
JournalInternational Journal of Pancreatology
Volume21
Issue number1
StatePublished - May 12 1997

Fingerprint

Blood Group Antigens
Tumor Cell Line
Polysaccharides
Asparagine
Adenocarcinoma
Cricetinae
Membrane Glycoproteins
nitrosobis(2-oxopropyl)amine
Cell Line
Glycoproteins
Mannosidases
Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase
Mesocricetus
Oligosaccharides
Neoplasms
Growth

Keywords

  • Blood group A
  • deoxymannojirimycin
  • endoglycosidases
  • oligosaccharide processing
  • pancreatic cancer
  • swainsonine

ASJC Scopus subject areas

  • Oncology
  • Endocrinology
  • Gastroenterology

Cite this

Modification of blood group A expression in human pancreatic tumor cell lines by inhibitors of N-glycan processing. / Schaffert, Courtney; Pour, Parviz M.; Chaney, William G.

In: International Journal of Pancreatology, Vol. 21, No. 1, 12.05.1997, p. 21-29.

Research output: Contribution to journalArticle

Schaffert, Courtney ; Pour, Parviz M. ; Chaney, William G. / Modification of blood group A expression in human pancreatic tumor cell lines by inhibitors of N-glycan processing. In: International Journal of Pancreatology. 1997 ; Vol. 21, No. 1. pp. 21-29.
@article{a8d240d3c9f84fc98edf841c71db0811,
title = "Modification of blood group A expression in human pancreatic tumor cell lines by inhibitors of N-glycan processing",
abstract = "Pancreatic adenocarcinomas induced in Syrian hamsters by N- nitrosobis(2-oxopropyl)amine (BOP) treatment express blood group A (BGA) antigen, which was previously shown by this lab to be expressed on multiantennary asparagine (Asn)-linked glycans attached to membrane glycoproteins. To determine if a similar expression pattern was found in humans, three human pancreatic ductal adenocarcinoma cell lines (CD18, CD11, and Capan 1) from individuals of blood type A were analyzed and shown to express BGA antigen on membrane glycoproteins similar in molecular mass to those found in hamster tumor cells. The BGA antigen was located on Asn- linked oligosaccharides in all three human cell lines, as indicated by loss of activity after peptide:N-glycosidase F (PNGase F) treatment. Also, as shown previously in hamster pancreatic tumor cells, BGA expression at the surface of the human cell lines was blocked by growth of the cells in media containing deoxymannojirimycin (dMM), an inhibitor of mannosidase 1. These results demonstrate that the BGA antigen is on Asn-linked glycans in human pancreatic adenocarcinoma cells and that these glycoproteins are processed similarly to the BGA glycoproteins in hamster pancreatic adenocarcinoma.",
keywords = "Blood group A, deoxymannojirimycin, endoglycosidases, oligosaccharide processing, pancreatic cancer, swainsonine",
author = "Courtney Schaffert and Pour, {Parviz M.} and Chaney, {William G.}",
year = "1997",
month = "5",
day = "12",
language = "English (US)",
volume = "21",
pages = "21--29",
journal = "Journal of Gastrointestinal Cancer",
issn = "1941-6628",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - Modification of blood group A expression in human pancreatic tumor cell lines by inhibitors of N-glycan processing

AU - Schaffert, Courtney

AU - Pour, Parviz M.

AU - Chaney, William G.

PY - 1997/5/12

Y1 - 1997/5/12

N2 - Pancreatic adenocarcinomas induced in Syrian hamsters by N- nitrosobis(2-oxopropyl)amine (BOP) treatment express blood group A (BGA) antigen, which was previously shown by this lab to be expressed on multiantennary asparagine (Asn)-linked glycans attached to membrane glycoproteins. To determine if a similar expression pattern was found in humans, three human pancreatic ductal adenocarcinoma cell lines (CD18, CD11, and Capan 1) from individuals of blood type A were analyzed and shown to express BGA antigen on membrane glycoproteins similar in molecular mass to those found in hamster tumor cells. The BGA antigen was located on Asn- linked oligosaccharides in all three human cell lines, as indicated by loss of activity after peptide:N-glycosidase F (PNGase F) treatment. Also, as shown previously in hamster pancreatic tumor cells, BGA expression at the surface of the human cell lines was blocked by growth of the cells in media containing deoxymannojirimycin (dMM), an inhibitor of mannosidase 1. These results demonstrate that the BGA antigen is on Asn-linked glycans in human pancreatic adenocarcinoma cells and that these glycoproteins are processed similarly to the BGA glycoproteins in hamster pancreatic adenocarcinoma.

AB - Pancreatic adenocarcinomas induced in Syrian hamsters by N- nitrosobis(2-oxopropyl)amine (BOP) treatment express blood group A (BGA) antigen, which was previously shown by this lab to be expressed on multiantennary asparagine (Asn)-linked glycans attached to membrane glycoproteins. To determine if a similar expression pattern was found in humans, three human pancreatic ductal adenocarcinoma cell lines (CD18, CD11, and Capan 1) from individuals of blood type A were analyzed and shown to express BGA antigen on membrane glycoproteins similar in molecular mass to those found in hamster tumor cells. The BGA antigen was located on Asn- linked oligosaccharides in all three human cell lines, as indicated by loss of activity after peptide:N-glycosidase F (PNGase F) treatment. Also, as shown previously in hamster pancreatic tumor cells, BGA expression at the surface of the human cell lines was blocked by growth of the cells in media containing deoxymannojirimycin (dMM), an inhibitor of mannosidase 1. These results demonstrate that the BGA antigen is on Asn-linked glycans in human pancreatic adenocarcinoma cells and that these glycoproteins are processed similarly to the BGA glycoproteins in hamster pancreatic adenocarcinoma.

KW - Blood group A

KW - deoxymannojirimycin

KW - endoglycosidases

KW - oligosaccharide processing

KW - pancreatic cancer

KW - swainsonine

UR - http://www.scopus.com/inward/record.url?scp=0030893094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030893094&partnerID=8YFLogxK

M3 - Article

C2 - 9127170

AN - SCOPUS:0030893094

VL - 21

SP - 21

EP - 29

JO - Journal of Gastrointestinal Cancer

JF - Journal of Gastrointestinal Cancer

SN - 1941-6628

IS - 1

ER -